Sort
38,696 grants matching “als”
Structural analysis of dynamins involved in mitochondrial morphology
$810,486Jenny E Hinshaw · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Project I - Transcriptomic Analysis of Structural Birth Defects in Mouse Developmental Mutants
$810,284David R. Beier · Seattle Children'S Hospital · P01 · FY2024 · HD
Directed Evolution of Novel AAVs and Regulatory Elements for Selective Microglial Gene Expression
$810,122David V Schaffer · University Of California Berkeley · R01 · FY2023 · NS
Effectiveness of Suicide Hotline Training
$809,819Madelyn S Gould · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2009 · MH
Genetic Expression of Lentigo Malignant Melanoma - UCSF consortium
$809,756Boris C Bastian · Wistar Institute · P01 · FY2007 · CA
TNFRSF13B polymorphisms and immunity to transplantation
$809,740Marilia Isabel Cascalho · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
A MULTIMODAL AND SPATIALLY RESOLVED DISSECTION OF ANTISENSE OLIGONUCLEOTIDE THERAPY OF FUS-RELATED ALS DISEASE PROGRESSION
$809,698The Trustees Of Columbia University In The City Of New York · · FY2022 · Defense Health Agency
Genetic etiology of Amyotrophic Lateral Sclerosis
$809,613Bryan Traynor · National Institute On Aging · ZIA · FY2015 · AG
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
$809,593Karen Macleod · Amprion, Inc. · U44 · FY2021 · NS
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
$809,593Karen Macleod · Amprion, Inc. · U44 · FY2022 · NS
HIV-Receptor Interactions and Related Anti-HIV Strategies
$809,592Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Quantification of Myocardial Perfusion
$809,560Andrew Arai · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Linking the Development of Association Cortex Plasticity to Trans-Diagnostic Psychopathology in Youth
$809,387Theodore Satterthwaite · University Of Pennsylvania · R01 · FY2023 · MH
Diabetes and Periodontics Trial - Coordinating Center
$809,348Leslie G. Hyman · State University New York Stony Brook · U01 · FY2011 · DE
PRECLINICAL CHARACTERIZATION OF AZVIII-7-18, A NOVEL PAULLONE DERIVATIVE FOR THE TREATMENT OF ALS
$809,262The Trustees Of Columbia University In The City Of New York · · FY2022 · Department of the Army
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS
$809,219Christopher Chad Quarles · St. Joseph'S Hospital And Medical Center · R61 · FY2022 · NS
Regulation of human dendritic cell activation
$809,152Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Neuroimaging of Brain Circuits and Neurogenetic Mechanisms in Normal Cognition
$809,007Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2012 · MH
CHCHD10 Frontotemporal Dementia, Molecular Mechanisms and Therapeutic Strategies
$808,996Hibiki Fujita · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
Genetic Expression of Lentigo Malignant Melanoma - UCSF consortium
$808,692Boris C Bastian · Wistar Institute · P01 · FY2008 · CA
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia
$808,578Aliza Pham Wingo · Emory University · R01 · FY2022 · AG
Single-cell Analysis of Normal and Perturbed Dynamic and Spatial Biological Systems
$808,391Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2022 · AG
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2024 · AG
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases
$808,198Janghoo Lim · Yale University · R01 · FY2021 · AG